Lutein/Zeaxanthin and Macular Health is an article discussing antioxidents and protection against the oxidizing ultraviolet radiation of the sun. The best dietary sources of antioxidants in general, and carotenoids specifically, are fruits and vegetables ­ and the more brightly colored, the better. Lutein and zeaxanthin are yellow pigments found in high concentrations in yellow fruits and vegetables as well as in dark green, leafy vegetables. In particular, spinach, kale and collard greens contain high levels of these two carotenoids.

By the second week I started to notice that my face and my stomach looked less puffy. Score! I saw this as a sign that inflammation in my system was going down. One of the most remarkable changes was in my mood. I felt generally happy and positive. I would say I’m a positive person in general, but I do get stressed out easily. The margin for getting really stressed got a little thicker, and I was simply able to deal better.


Due to CrossFit's official partnership with Reebok, competitors at the 2015 Games were banned from wearing Nike footwear.[32] Nike arranged for several trucks to be parked near the main entrance to the arena, which served as mobile billboards with the slogan "Don't ban our shoe, beat our shoe".[33] The partnership also prohibits Nike from labeling its Metcon shoes as intended for CrossFit – the brand uses the term "high intensity training" instead.[32]
A 2015 study in the Journal of the American College of Cardiology found that 76 people who followed the Paleo diet for 60 days (as well as those who followed vegan, Mediterranean and DASH plans for the same length of time) lost an average of 9 pounds and showed improvement in their blood pressure levels. The effects were greatest and most sustained among people who also attended regular diet support group meetings.

The WHO trial (so named because the international team of principal investigators contained World Health Organization members) tested the potential of clofibrate, a “pre-statin” cholesterol-lowering agent, to reduce heart attack morbidity and mortality. The investigators ultimately concluded that clofibrate "cannot be recommended as a lipid-lowering drug for community-wide primary prevention of ischaemic heart disease.” Nevertheless, clofibrate remained in use until 2002, when it was pulled for increasing cancer rates. In their review of studies such as the WHO trial, Uffe Ravnskov and David Diamond observe, “Despite the largely disappointing findings from 50 years of cholesterol lower[ing] trials, the indictment and conviction of cholesterol as the causal agent in CVD [cardiovascular disease] has stood the test of time. … [Yet] the grand effort to reduce cholesterol as a strategy to improve health has failed.”
×